S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer

Completed · Not applicable · Has a placebo group

Conditions studied: brca1 Mutation Carrier, brca2 Mutation Carrier, Breast Cancer

In brief

RATIONALE: Cholecalciferol may prevent breast cancer in premenopausal women. PURPOSE: This randomized phase II trial is studying how well cholecalciferol works in preventing breast cancer in premenopausal women.

Key facts

Study ID
NCT01097278
Run by
SWOG Cancer Research Network
People needed
208
Starts
2011-11-01
Expected to finish
2017-09-01
Last updated by the study team
2017-11-24

Who can join

Age: 18 and older, up to 50. Sex: female. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.